Thursday 28 November 2024

We have some fantastic role models in NNL who are supporting Movember by sporting moustaches for the month of November. They are raising awareness of men’s mental health and suicide prevention, prostate cancer and testicular cancer.  

Movember is particularly poignant time of year for us – as we are working towards novel treatments for cancer – that could be used to treat prostate cancer in the future. NNL is now able to extract an isotope of lead, specifically lead-212 from stored material. This can be used by one of our academic partners, Queen Mary’s Barts Cancer Institute in its research into the future of radiotherapy at the molecular level. It is called targeted alpha therapy and can be used to destroy cancer cells with minimal damage to surrounding tissues.  

Professor Tim Tinsley, National Nuclear Laboratory said: “The promise of innovative new approaches for treating prostate and other cancers is an exciting area for NNL to apply its nuclear and radiochemistry experience. I’m delighted to be supporting this research and to work with researchers at Queen Mary University of London.”  

Professor Jane Sosabowski, Queen Mary’s Barts Cancer Institute adds: “Movember is a thought provoking and positive campaign, a good time to reflect on how much we value our collaboration with NNL and Radionuclides for Health UK on using radionuclides from nuclear waste to make exciting new targeted alpha therapies for prostate and other cancers available to UK patients in the future.”  

If you want to support the Movember charity or find out about the 1320 men’s health projects they have delivered globally, click here.